Search Results - "Hoon, D"

Refine Results
  1. 1

    Founder affiliations: jobseeker reactions and impact on employee recruitment by start-up ventures by Chung, Seung Hoon D., Parker, Simon C.

    Published in Small business economics (01-06-2023)
    “…Many entrepreneurs face challenges in hiring employees, in part because of information asymmetries between start-ups and jobseekers. This paper argues that the…”
    Get full text
    Journal Article
  2. 2

    Assessment of DNA methylation status in early stages of breast cancer development by van Hoesel, A Q, Sato, Y, Elashoff, D A, Turner, R R, Giuliano, A E, Shamonki, J M, Kuppen, P J K, van de Velde, C J H, Hoon, D S B

    Published in British journal of cancer (28-05-2013)
    “…Background: Molecular pathways determining the malignant potential of premalignant breast lesions remain unknown. In this study, alterations in DNA methylation…”
    Get full text
    Journal Article
  3. 3

    Epigenetic status of LINE-1 predicts clinical outcome in early-stage rectal cancer by Benard, A, van de Velde, C J H, Lessard, L, Putter, H, Takeshima, L, Kuppen, P J K, Hoon, D S B

    Published in British journal of cancer (10-12-2013)
    “…Background: We evaluated the clinical prognostic value of methylation of two non-coding repeat sequences, long interspersed element 1 (LINE-1) and Alu, in…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Functional RET G691S polymorphism in cutaneous malignant melanoma by Narita, N, Tanemura, A, Murali, R, Scolyer, R A, Huang, S, Arigami, T, Yanagita, S, Chong, K K, Thompson, J F, Morton, D L, Hoon, D S

    Published in Oncogene (27-08-2009)
    “…RET proto-oncogene encodes a receptor tyrosine kinase whose ligand is glial cell line-derived neurotrophic factor (GDNF), and its polymorphism at G691S…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Transcriptional repression of IFNβ1 by ATF2 confers melanoma resistance to therapy by Lau, E, Sedy, J, Sander, C, Shaw, M A, Feng, Y, Scortegagna, M, Claps, G, Robinson, S, Cheng, P, Srivas, R, Soonthornvacharin, S, Ideker, T, Bosenberg, M, Gonzalez, R, Robinson, W, Chanda, S K, Ware, C, Dummer, R, Hoon, D, Kirkwood, J M, Ronai, Z A

    Published in Oncogene (12-11-2015)
    “…The resistance of melanoma to current treatment modalities represents a major obstacle for durable therapeutic response, and thus the elucidation of mechanisms…”
    Get full text
    Journal Article
  8. 8

    Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins by Kim, J, Reber, H A, Dry, S M, Elashoff, D, Chen, S L, Umetani, N, Kitago, M, Hines, O J, Kazanjian, K K, Hiramatsu, S, Bilchik, A J, Yong, S, Shoup, M, Hoon, D S B

    Published in Gut (01-11-2006)
    “…Background: Despite intent to cure surgery with negative resection margins, locoregional recurrence is common in pancreatic cancer. Aims: To determine whether…”
    Get full text
    Journal Article
  9. 9

    Transcriptional repression of IFN beta 1 by ATF2 confers melanoma resistance to therapy by Lau, E, Sedy, J, Sander, C, Shaw, M A, Feng, Y, Scortegagna, M, Claps, G, Robinson, S, Cheng, P, Srivas, R, Soonthornvacharin, S, Ideker, T, Bosenberg, M, Gonzalez, R, Robinson, W, Chanda, S K, Ware, C, Dummer, R, Hoon, D, Kirkwood, J M, Ronai, Z A

    Published in Oncogene (12-11-2015)
    “…The resistance of melanoma to current treatment modalities represents a major obstacle for durable therapeutic response, and thus the elucidation of mechanisms…”
    Get full text
    Journal Article
  10. 10

    Aberrant hypermethylation in primary tumours and sentinel lymph node metastases in paediatric patients with cutaneous melanoma by Huynh, K.T., Takei, Y., Kuo, C., Scolyer, R.A., Murali, R., Chong, K., Takeshima, L., Sim, M-S., Morton, D.L., Turner, R.R., Thompson, J.F., Hoon, D.S.B.

    Published in British journal of dermatology (1951) (01-06-2012)
    “…Summary Background  Debate on how to manage paediatric patients with cutaneous melanoma continues, particularly in those with sentinel lymph node (SLN)…”
    Get full text
    Journal Article
  11. 11

    Molecular analysis of sentinel lymph nodes and search for molecular signatures of the metastatic potential of breast cancer by Hoon, D S, Bernet, L, Cano, R, Viale, G

    “…Molecular assays are a new and invaluable tool in the assessment of axillary lymph node status and metastatic potential of breast cancer. Many protocols for…”
    Get full text
    Journal Article
  12. 12

    Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients by Bostick, P J, Chatterjee, S, Chi, D D, Huynh, K T, Giuliano, A E, Cote, R, Hoon, D S

    Published in Journal of clinical oncology (01-08-1998)
    “…This study was performed to evaluate the potential of specific mRNA markers to detect micrometastases by reverse-transcriptase polymerase chain reaction…”
    Get more information
    Journal Article
  13. 13

    Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21 by Yamano, T, Kaneda, Y, Hiramatsu, S H, Huang, S, Tran, A N, Giuliano, A E, Hoon, D S B

    Published in Cancer gene therapy (01-05-2007)
    “…Human telomerase reverse transcriptase (TERT) has been considered a potential tumor-associated antigen for active-specific immunotherapy. However, effective…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Prognostic Significance of Occult Metastases Detected by Sentinel Lymphadenectomy and Reverse Transcriptase–Polymerase Chain Reaction in Early-Stage Melanoma Patients by BOSTICK, P. J, MORTON, D. L, TURNER, R. R, HUYNH, K. T, WANG, H.-J, ELASHOFF, R, ESSNER, R, HOON, D. S. B

    Published in Journal of clinical oncology (01-10-1999)
    “…Detection of micrometastases in the regional tumor-draining lymph nodes is critical for accurate staging and prognosis in melanoma patients. We hypothesized…”
    Get full text
    Journal Article
  16. 16

    Detection of occult metastatic breast Cancer cells in blood by a multimolecular marker assay: Correlation with clinical stage of disease by TABACK, Bret, CHAN, Arden D, KUO, Christine T, BOSTICK, Peter J, WANG, He-Jing, GIULIANO, Armando E, HOON, Dave S. B

    Published in Cancer research (Chicago, Ill.) (15-12-2001)
    “…Currently, molecular markers offer the unique opportunity to identify occult metastasis in early stage cancer patients not otherwise detected with conventional…”
    Get full text
    Journal Article
  17. 17

    Molecular Staging of Early Colon Cancer on the Basis of Sentinel Node Analysis: A Multicenter Phase II Trial by BILCHIK, Anton J, SAHA, Sukamal, WIESE, David, STONECYPHER, James A, WOOD, Thomas F, SOSTRIN, Stuart, TURNER, Roderick R, WANG, He-Jing, MORTON, Donald L, HOON, Dave S. B

    Published in Journal of clinical oncology (15-02-2001)
    “…Approximately 30% of patients with American Joint Committee on Cancer stage I or II colorectal cancer (CRC) develop systemic disease. We hypothesized that…”
    Get full text
    Journal Article
  18. 18

    Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence by HOON, D. S. B, BOSTICK, P, KUO, C, OKAMOTO, T, WANG, H.-J, ELASHOFF, R, MORTON, D. L

    Published in Cancer research (Chicago, Ill.) (15-04-2000)
    “…Improvement is needed in the ability to evaluate the prognosis of melanoma patients who are clinically disease-free but likely to develop recurrent metastatic…”
    Get full text
    Journal Article
  19. 19
  20. 20

    RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization by Zhou, W Z, Hoon, D S, Huang, S K, Fujii, S, Hashimoto, K, Morishita, R, Kaneda, Y

    Published in Human gene therapy (01-11-1999)
    “…An RNA melanoma vaccine was investigated to induce protective immunity in a mouse-melanoma model. LacZ mRNA was synthesized in vitro by pSFV3 expression vector…”
    Get more information
    Journal Article